Search Results

1 - 10 of 1,668 items :

Clear All
Contemporary pharmacological obesity treatments

REFERENCES 1. Ben J.J., Stephen B.: The new era of drug therapy for obesity: the evidence and the expectations. Drugs , 75, 935, 2015. 2. Bragg R., Crannage E.: Review of pharmacotherapy options for the management of obesity. J. Ann. Assoc. Nurse. Pract ., 10,1002/2327-6924.12279, 2015. 3. Bray G.A., Ryan D.H.: Update on obesity pharmacotherapy. Ann. NY. Acad. Sci. , 1311, 1-13, 2014. 4. Główny Urząd Statystyczny: Notatka informacyjna Zdrowie i zachowanie zdrowotne mieszkańców Polski w świetle Europejskiego Ankietowego Badania Zdrowia

Open access
Obesity and Knee Arthroscopy – a Review

References 1. Collaboration NCDRF. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016;387:1377-1396. 2. Seidell JC, Halberstadt J. Obesity: The obesity epidemic in the USA - no end in sight? Nat Rev Endocrinol. 2016;12:499-500. 3. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in Obesity Among Adults in the United States, 2005 to 2014. JAMA. 2016

Open access
Obesity in Childhood and Adolescence, Genetic Factors

REFERENCES 1. Memedi R, Tasic V, Nikolic E, Jancevska A, Gucev Z. Obesity in childhood and adolescence, genetic factors. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2013;34(2):85-89. 2. Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes. 2006;1(1):11-25. 3. Ebbeling CB, Pawlak DB, Ludwig DS. Childhood obesity: publichealth crisis, common sense cure. Lancet. 2002;360(9331):473–482. 4. Krstevska-Konstantinova M, Jancevska A, Kocova M, Gucev Z. Weight, height and puberty in a cohort of Macedonian

Open access
Obesity Treatment Strategies

References 1. WHO - Obesity and overweight. Fact sheet Nr. 311, Updated March 2011. 2. Feller S, Boeing H, Tobias Pischon T. Body Mass Index, Waist Circumference, and the Risk of Type 2 Diabetes Mellitus. Dtsch Arztebl Int. 2010. 107(26):470–476. 3. vanDis I, Kromhout D, Geleijnse JM, Boer JM, Verschuren WM - BMI and WC predict both 10-year nonfatal and fatal cardiovascular disease risk: study conducted in 20,000 Dutch men and women aged 20-65 years. Eur J Cardiovasc Prev Rehabil, 2009, 16(6):729-734. 4. Pischon T, Boeing H, Hoffmann K, et

Open access
Physiotherapy in the comprehensive treatment of obesity

References 1. Adams K.F., Schatzkin A., Harris T.B.: Overweight, obesity and mortality in a large prospective cohort of persons 50 to 71 years old. N. Engl. J. Med. 2006; 355: 763-778. 2. Balkau B., Deanfield J.E., Després J.P., Bassand J.P., Fox .KA., Smith SC Jr., Barter P., Tan C.E., Van Gaal L., Wittchen H.U., Massien C, Haffne, International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries

Open access
„Obesity Paradox“ – Fiction or a Fact?

of pure heart rate reduction. Medicographia, 2008. 30, 3:222-3. 8. Scaglione R, Argano C, Di Chiara T, Licata G. Obesity and cardiovascular risk: the new public health problem of worldwide proportions. Expert Rev Cardiovasc Ther. 2004; 2(2): 203-212. 9. Poirier P, Eckel RH. Obesity and Cardiovascular Disease. Current Atherosclerosis Reports. 2002; 4:448-453. 10. World Health Organization. Obesity: preventing and managing the global epidemic - report of a WHO consultation on obesity. World Health Organisation, Geneva

Open access
Iron deficiency anemia and megaloblastic anemia in obese patients

REFERENCES 1. LOW S, CHIN, MC, DEURENBERG-YAP, M. Review on epidemic of obesity. Ann. Acad. Med. Singapore 2009; 38 :57–59. 2. DATZ C, FELDER, TK, NIEDERSEER D, AIGNER E. Iron homeostasis in the metabolic syndrome. Eur. J. Clin. Investig. 2013; 43 : 215–224. 3. Lear S.A, Teo K, Gasevic D, Zhang, X, Poirier P.P, RANGARAJAN S, et al. The association between ownership of common household devices and obesity and diabetes in high, middle and low income countries . Can. Med. Assoc. J. 2014; 186: 258–266. 4. MYINT PK, KWOK CS, LUBEN RN

Open access
Diabetes Mellitus, Obesity and Underlying Non Alcoholic Fatty Liver Disease - Independent Risk Factors for Hepatocellular Carcinoma

References 1. Gupta K, Krishnaswamy G, Karnad A, Peiris AN . Insulin: a novel factor in carcinogenesis. Am J Med Sci 323: 140-145, 2002. 2. El-Serag HB, Tran T, Everhart JE . Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126: 460-468, 2004. 3. Caldwell SH, Crespo DM, Kang HS, Al- Osaimi AM . Obesity and hepatocellular carcinoma. Gastroenterology 127[Suppl. 1]: S97-S103, 2004. 4. Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL

Open access
Our Experience with Laparoscopic Sleeve Gastrectomy in the Therapy of Morbid Obesity

References 1. Obesity and overweight. Fact sheet Nr.311[online]. Geneve : WHO, March 2013]. Dostupné na internete: < factsheets/ fs311/en/>. 2. DUKÁT A, LIETAVA K, KRAHULEC B et al. IDEA - prvé výsledky o prevalencii abdominálnej obezity na Slovensku. Via practica 2006; 3 (12): 554-558. 3. DOLEŽALOVÁ K et al. Bariatrická chirurgie a primární péče. Praha : Axonite CZ; 2012. 4. KASHYAP SR., GATMAITAN P, BRETHAUER S. et al. Bariatric surgery for type 2 diabetes

Open access
Abdominal Obesity – A Cardiometabolic Risk Factor

References 1. Phillips CM, Tierney AC, Perez-Martinez P et al. Obesity and body fat classification in the metabolic syndrome: Impact on cardiometabolic risk metabotype. Obesity (Silver Spring) 21: E154-E161, 2013. 2. Bala C. Complicațiile obezității. În Șerban V. Tratat român de boli metabolice, vol. 2, p.379-86, Editura BrumaR, Timișoara, 2011 3. Arnold AC, Diz DI. Endogenous leptin contributes to baroreflex suppression within the solitary tract nucleus of aged rats. Am J Physiol Heart Circ Physiol 307: H1539-H

Open access